Press Releases

A team led by Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at the George Washington University (GW) Cancer Center and Eduardo M. Sotomayor, MD, director of the GW Cancer Center, received a 2018 Education Research Grant Award from the Center…

Lorien Abroms, ScD, associate professor of prevention and community health at the Milken Institute School of Public Health at GW, has been named interim associate center director for population sciences and policy at the GW Cancer Center.

WASHINGTON (February 22, 2018)-The George Washington University (GW) Cancer Center recently welcomed 24 multidisciplinary health care teams from across the country to its inaugural TEAM (Together, Equitable, Accessible, Meaningful) Training program.

The GW School of Medicine and Health Sciences will participate in the First International Scientific Research Summit of the GW-Spain Consortium in Madrid. The summit was created in partnership with the GW Cancer Center, SMHS researchers, the school's Office of International Medicine Programs, and…

Dr. Rachel Brem joins Kathie Lee Gifford and Hoda Kotb with the story of how her mother’s breast cancer diagnosis inspired her to become a leading radiologist, and at the age of 37, confirm her own breast cancer diagnosis. (Pink Power on TODAY is sponsored by the Genius 3D Mammography Exam.)

WASHINGTON (Oct. 18, 2017) - The George Washington University (GW) Cancer Center is pleased to announce that a new state-of-the-art mobile mammography van, known as the GW Mammovan, will provide breast cancer screening to women in the Washington, D.C. region.

Eight George Washington University alumni will be honored this year with the Distinguished Alumni Achievement Award, the highest form of recognition given annually by the university and the George Washington Alumni Association to a graduate.

Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at GW Cancer Center, accepted a check from the Avon Foundation at the annual Avon Walk in Washington, D.C. The money will fund a patient navigator who will provide resources to help breast cancer…

A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.

Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.